Mattiucci, Gian Carlo
 Distribuzione geografica
Continente #
NA - Nord America 5.663
EU - Europa 5.096
AS - Asia 3.903
SA - Sud America 851
AF - Africa 115
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 14
Totale 15.659
Nazione #
US - Stati Uniti d'America 5.538
DE - Germania 1.933
SG - Singapore 1.895
CN - Cina 1.003
SE - Svezia 995
BR - Brasile 708
IT - Italia 472
UA - Ucraina 333
FR - Francia 330
IN - India 243
GB - Regno Unito 227
IE - Irlanda 221
VN - Vietnam 172
ID - Indonesia 148
FI - Finlandia 139
RU - Federazione Russa 101
TR - Turchia 93
PL - Polonia 82
BE - Belgio 62
CA - Canada 61
AR - Argentina 57
BD - Bangladesh 49
HK - Hong Kong 43
IQ - Iraq 40
NL - Olanda 38
CZ - Repubblica Ceca 37
MX - Messico 37
JP - Giappone 35
CI - Costa d'Avorio 34
ZA - Sudafrica 33
IR - Iran 31
AT - Austria 26
EC - Ecuador 23
ES - Italia 21
SA - Arabia Saudita 19
PK - Pakistan 16
AU - Australia 14
CO - Colombia 14
VE - Venezuela 13
KR - Corea 12
UY - Uruguay 12
UZ - Uzbekistan 12
AZ - Azerbaigian 11
CH - Svizzera 11
LT - Lituania 11
MA - Marocco 11
EU - Europa 9
KE - Kenya 9
RO - Romania 9
CL - Cile 8
KZ - Kazakistan 8
IL - Israele 7
NO - Norvegia 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
JM - Giamaica 6
JO - Giordania 6
LU - Lussemburgo 6
PS - Palestinian Territory 6
TN - Tunisia 6
AM - Armenia 5
LK - Sri Lanka 5
NP - Nepal 5
OM - Oman 5
PE - Perù 5
PT - Portogallo 5
AL - Albania 4
BG - Bulgaria 4
DK - Danimarca 4
EG - Egitto 4
KG - Kirghizistan 4
KW - Kuwait 4
PA - Panama 4
PY - Paraguay 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TT - Trinidad e Tobago 4
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
LB - Libano 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BZ - Belize 2
GE - Georgia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
PR - Porto Rico 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 15.640
Città #
Chandler 1.081
Singapore 876
Ashburn 546
Jacksonville 227
Beijing 225
Dublin 221
Ann Arbor 216
San Mateo 202
New York 194
Dearborn 145
Los Angeles 145
Nanjing 137
Jakarta 134
Wilmington 131
Munich 122
Woodbridge 117
Boston 115
The Dalles 105
Milan 97
Nürnberg 92
Marseille 72
Princeton 69
São Paulo 68
Warsaw 68
Bremen 67
Frankfurt am Main 65
Izmir 65
Ho Chi Minh City 64
Hefei 62
Brussels 61
Fairfield 60
Cattolica 59
Hyderabad 57
Lawrence 55
Dallas 54
Rome 54
Houston 53
Moscow 52
Seattle 49
Nanchang 45
Helsinki 43
Redwood City 43
Hong Kong 42
Buffalo 39
Hanoi 39
Abidjan 34
London 34
Zhengzhou 33
Detroit 30
Shenyang 29
Boardman 28
Kunming 28
Redmond 28
Chicago 27
Jiaxing 27
Leawood 27
Nuremberg 24
Augusta 23
Brooklyn 23
Tokyo 23
Cambridge 22
Johannesburg 21
Norwalk 21
Changsha 20
Tianjin 20
Turku 20
Toronto 19
Hebei 18
Kent 18
Pune 18
Santa Clara 18
Stockholm 18
Ottawa 17
Amsterdam 16
Düsseldorf 16
Shanghai 16
Belo Horizonte 15
Poplar 15
Brasília 14
Chennai 14
Curitiba 14
Phoenix 14
Rio de Janeiro 14
Atlanta 13
Baghdad 12
University Park 12
Vienna 12
Baku 11
Bexley 11
Fremont 11
Hangzhou 11
Lauterbourg 11
Mountain View 11
North Bergen 11
San Francisco 11
Seoul 11
Washington 11
Ankara 10
Ardabil 10
Auburn Hills 10
Totale 7.538
Nome #
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 248
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 210
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 210
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 206
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 205
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 199
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 187
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 180
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 177
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 175
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 175
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 173
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 171
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 170
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 169
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 169
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 168
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 167
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 167
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 164
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 164
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 161
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 159
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 157
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 157
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 155
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 154
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 152
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 152
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 150
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 149
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 148
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 146
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 145
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 145
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 145
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 144
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 143
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 141
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 138
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 137
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 137
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 137
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 136
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 136
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 135
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 135
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 133
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 133
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 129
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 129
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 128
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 125
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 125
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 121
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 121
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 120
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 119
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 118
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 117
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 116
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 115
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 112
New standards for the management of nose vestibule malignancies 111
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 111
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 109
The impact of radiomics in diagnosis and staging of pancreatic cancer 109
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases 108
Can automation in radiotherapy reduce costs? 106
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 106
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 106
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 105
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 105
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 104
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 103
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 102
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 102
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience. 99
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 99
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 99
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 98
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 97
Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient 97
Radiation therapy for prostate cancer: What's the best in 2021 97
Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls 96
In reply to Yamazaki et al 95
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 95
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients 95
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 95
Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy 93
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach 92
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 91
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 91
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 90
Prostheses irradiation in high risk breast cancer patients: clinical and aesthetic outcomes in retrospective series 89
Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis 89
Patients’ satisfaction by smileintm totems in radiotherapy: A two-year mono-institutional experience 88
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 86
Optimized stereotactic volumetric modulated arc therapy as an alternative to brachytherapy for vaginal cuff boost. A dosimetric study 83
Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas 82
Totale 13.232
Categoria #
all - tutte 65.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021437 0 0 0 0 0 46 64 20 107 52 133 15
2021/20221.261 121 65 16 127 57 41 21 198 55 102 212 246
2022/20232.796 371 389 220 464 161 336 139 240 323 31 92 30
2023/20241.259 45 340 41 161 46 192 55 89 11 38 123 118
2024/20252.533 58 87 176 95 270 83 77 130 394 268 508 387
2025/20263.488 952 175 313 670 1.149 229 0 0 0 0 0 0
Totale 15.835